Cystatin C, cognition, and brain MRI findings in 90+-year-olds

Neurobiol Aging. 2020 Sep:93:78-84. doi: 10.1016/j.neurobiolaging.2020.04.022. Epub 2020 Apr 29.

Abstract

Chronic kidney disease is emerging as a novel risk factor for cerebrovascular disease, but this association remains largely unexplored in older adults. Cystatin C is a more accurate measure than creatinine of kidney function in the elderly. We evaluated cystatin C, cognitive function, and brain imaging in 193 participants from The 90+ Study neuroimaging component. The mean age was 93.9 years; 61% were women. Mean cystatin C was 1.62 mg/L with estimated glomerular filtration rate 39.2 mL/min/1.73 m2. Performance on measures of global cognition, executive function, and visual-spatial ability declined at higher tertiles of cystatin C (lower kidney function). Higher cystatin C was significantly associated with infratentorial microbleeds and lower gray matter volume. Adjusted risk of incident dementia was increased in the middle and high cystatin C tertile groups compared with the low group (hazard ratio in highest tertile 3.81 [95% confidence interval 1.14-12.7]), which appeared to be explained in part by the presence of cerebral microbleeds. Overall, cystatin C was associated with cognitive performance, brain imaging pathology, and decline to dementia in this oldest-old cohort.

Keywords: Aging; Brain MRI; Chronic kidney disease; Cognition.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Age Factors
  • Aged, 80 and over
  • Aging / pathology*
  • Aging / psychology*
  • Biomarkers / blood
  • Brain / diagnostic imaging*
  • Brain / pathology*
  • Brain / physiopathology
  • Cognition*
  • Cystatin C / blood*
  • Dementia / diagnosis*
  • Dementia / psychology
  • Female
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Renal Insufficiency, Chronic / diagnosis

Substances

  • Biomarkers
  • Cystatin C